Antimicrobial resistance grant
This article was originally published in The Rose Sheet
Executive SummaryCenters for Disease Control & Prevention announces availability of roughly $600,000 in grant funding for fiscal 2002 for applied research aimed at "prevention and control of the emergence and spread of antimicrobial resistance" in the U.S. Program will focus on validation of national committee for clinical laboratory standards (NCCLS) breakpoints for human pathogens of public health importance, according to June 4 Federal Register notice. Research expected to begin Aug. 30 and continue for up to three years. Completed application forms, available at 1CDC's Web site, are due July 16...
You may also be interested in...
In its first ASH since acquiring Celgene and with competitors coming, Bristol presented pivotal results for liso-cel (JCAR017) that support a year-end US FDA submission as bb2121 nears a first-half of 2020 filing.
US FDA's Pediatric Experts, Not Review Division, Should Have Final Say On Pediatric Trials, Former Official Says
Former Associate Commissioner Janice Soreth says views of pediatric experts should take precedence over those of division directors regarding pediatric trials.